Toggle Nav
My Cart
Search
Menu

Scientific Posters

OriGene scientists are dedicated to the advancement of biological and medical science. They attend scientific conferences and share their ideas and findings with fellow scientists.

2024 American Association of Cancer Research

Target of Interest Title View PDF
MAGE-A3, MAGE-A4, PD-L1 MAGE-A3, MAGE-A4, and PD-L1 protein show co-expression in colon, lung and bladder cancer
MAGE-A3, IDH1, IL_1β MAGE-A3 co-expression with IDH1-R132H and IL-1β in colon cancer
DEFB4A Computational integration with phage library to optimize clones of DEFB4A antibodies for cancer diagnostics and therapeutics
CRISPR A Highly Efficient Donor System for CRISPR Knock-In Editing
PSCA, PD-L1 Exploring the relationship between PSCA and PD-L1 by a comprehensive tumor immunohistochemical analysis
MAGE-A3, MAGE-A4 Secretion of MAGE-A3 and MAGE-A4 in cell lines and lung cancer
MAGE-A3 MAGEA3 expression and secretion in MMR-MSH6 and MMR-PMS2 microsatellite-stable colorectal cancer

2023 American Association of Cancer Research

Target of Interest Title View PDF
MAGEA3 & MAGEA4 MAGEA3 and MAGEA4 proteins show co-expression in lung, bladder and colon cancer.
MAGEA3 MAGE-A3 expression with MMR-MSH6 screening suggests MAGE-A3 as a potential target for microsatellite-stable colorectal cancer.
MAGEA3 & MAGEA4 Colocalization of MAGE-A3 and MAGE-A4 in bladder cancer.

2022 National Society for Histotechnology

Target of Interest Title View PDF
MAGEA3 and MAGEA4 MAGEA3 and MAGEA4 have different expression pattern in lung cancer

2022 American Association for Clinical Chemistry Meeting

Target of Interest Title View PDF
MAGE-A3 Serum MAGE-A3 Is A Potential Prognostic Marker for Prostate Cancer

2022 American Association of Cancer Research Annual Meeting

Target of Interest Title View PDF
MAGE A renewable IHC control tool CytoSection for defining MAGEA3, MAGEA4, and MAGEA9 antibody specificity
HSD17B13 Overexpression of HSD17B13 induced G1 arrest in hepatic cell lines detected by anti-HSD17B13 recombinant rabbit monoclonal antibody

2020 American Association of Cancer Research Virtual Annual Meeting

Target of Interest Title View PDF
PD-L1 PD-L1 and Diacylglycerol Kinase alpha (DGKa) Expression in NSCLC and Bladder Cancer

2019 American Association of Cancer Research Annual Meeting

Target of Interest Title View PDF
CRISPR CRISPR KN2.0: A Universal Solution for Genome-Wide Gene Knockout/Knockin
PD-L1 Immune Cell Expression of LAG3 and TIM3 In The Tumor Micro Environment Of PD-L1 Positive/Negative Bladder Cancer, Melanoma, And Lung Cancer

2018 American Association of Cancer Research Annual Meeting

Target of Interest Title View PDF
PD-L1 Characterization of Two New Recombinant Rabbit anti-PDL1 Antibodies In Bladder Cancer, NSCLC, and Melanoma With Immune Cell Markers CD3, CD8A, CD20, CD68 and FOXP3

2016 American Association of Cancer Research Annual Meeting

Target of Interest Title View PDF
ALK A new, highly sensitive ALK antibody improves the screening of rearranged-ALK by IHC
LGR5 Evaluation of LGR5 protein expression in colon cancer stem cells
HER2 A screen of breast and colon cancers with HER2 antibody clone UMAB36 does not exhibit the cross-reactivity of clone 4B5 with HER4 protein

2015 American Association of Cancer Research Annual Meeting

Target of Interest Title View PDF
ALK The development of a highly sensitive mouse monoclonal antibody for screening ALK-rearrangements in lung cancers
HER2 Develop a Highly Specific HER2 Antibody for IHC Screening in Breast and Gastric Cancers
Ki67 The Development of a Highly Specific IHC Monoclonal Antibody against Ki-67
MET The development of a highly specific mouse monoclonal MET antibody for IHC application

2015 Experimental Biology

Target of Interest Title View PDF
LGR5 The Development and Evaluation of Highly Specific Monoclonal Antibodies against Human LGR5
PD-1 The Development of an Anti-PD1 Mono-Specific Antibody (UMAB199) for Anatomic Pathology

Product Support

Related Products